ArchiveSCV
the-signal.com. The Santa Clarita Valley Signal. Back to the collection.

· the-signal.com, Wayback capture

Straight Talk

Need ideas on where to invest?

Deciding which types of funds are best to invest in for positive returns has always been a challenge for investors, no matter what’s happening in the market. So, if you’re looking for a couple of ideas, here’s what some pros are suggesting.

Sheldon Jacobs, publisher of The No-Load Fund Investor, thinks one sector ripe for “outsize returns over the next five to 10 years” is health and biotech funds.

His reasoning? Partly the aging baby boomer demographics combined with the defensive nature of these stocks, meaning that people typically will spend money on their health and health care no matter what’s going on in the economy.

Then there is profitability. Forget the Internet stock bubble, in which dreams were played, and not much made. There are many established health and biotech companies out there with track records that make viable products. Add to that the potential profitability if cures for chronic diseases such as Alzheimer’s and cancer are found. And, there is also the promise offered by the brand-new world of genomics.

On the downside, a couple of the many risks include the fact that the price-earnings ratio on health and biotech stocks— and the funds investing in them— is higher than average. And the risk factor in developing new drugs is also high. “Right now, about one in 50 survive from scientific idea to human testing,” says Jacobs. “Even from that point, there is a tremendous attrition rate so that for every compound that starts in preliminary human testing, the FDA approves only about one in 10.”

Even though this sector can be a risky one, if you find the health and biotech arena exciting, Jacobs suggests the best play is a diversified one. Look for a fund that not only diversifies its holdings by companies, but also among various sub-sectors .

His recommendation for a conservative play is the Vanguard Health Care Fund. Its portfolio currently has the bulk of its assets— 68 percent— invested in health care companies. Middle-of-the-road suggestions include Invesco Health Sciences Fund, which currently has 56 percent of its assets invested in pharmaceuticals and 31 percent in biotechnology health care companies; T.Rowe Price Health Sciences Fund with 37 percent of its portfolio in biotechnology companies and 33 percent in pharmaceuticals; and American Century Life Sciences Fund with 44 percent of assets invested in pharmaceuticals and 23 percent in medical providers.

For those wanting to take maximum risk, his suggestion is the Genomics Fund. Pharmagenomics make up 45 percent of its portfolio, followed by 31 percent invested in monoclonal antibodies companies.

Should you decide to research any of Jacobs’ fund suggestions, you’ll find all of their year-to-date total return performance numbers in minus territory. Don’t let that alarm you. While it’s impossible to predict the future returns on any type of mutual fund, it’s not unusual to find this year’s dog funds performing well on future years’ performance lists.

For those interested in trends, Montgomery Asset Management thinks that there’s a new mega-trend on the horizon. In a white paper recently released by this San Francisco-based company, the potential of alternative energy sources is addressed in the report titled “New Power— The Next Frontier.”

The experts at Montgomery see this mega-trend as worldwide in scope and being driven by a number of factors. “When deregulation, technology and innovation combine in a major industry to lower prices, improve quality, simplify and personalize use, consumer adaptation can be beyond anyone’s expectations,” says Glen Hilton, Montgomery’s senior analyst and New Power expert.

Technologies that the report thinks will shape the new power industry of tomorrow include distributed power designed to decentralize power at its source; clean power, such as marketing surge-free and continuous power supplies to power-dependent users; green power, or renewable power; and e-power , which leverages power, moving it directly to consumers and away from suppliers.

And there you have it; a couple of new ideas to think about, cautiously.

Dian Vujovich’s column is distributed by the Newspaper Enterprise Association.

← Back to 2001

About this record

How it was held, read and classified

Record details

Morris ID
Not a Morris ID. This record is keyed ts-df:/business/guest/0801/080401b.html.
System
date-file pages (/desk/MMYY/MMDDYY.html)
Reading copy
the-signal.com
Chosen by: only copy held. On this copy: words 664 (e-mail addresses counted as one token); reader comments 0 (counted, not reproduced here); images 0.
Extracted by
datefile:START_STORY
signal-extract/0.15 (2026-11-16)

Other copies

Held
None. The holding has this article from one host only.

How it was classified

Label
clearly-local
Judgment
A machine’s (recorded as machine), kept as one so it can be revisited.
Classifier
signal-localclass/0.7 (2026-11-12)
Local signals
  • url:datefile_business
National signals
none fired
Scores
local 3, national 0